Status: Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Participants needed: 900
Trial details
Biological sex: AllType: ObservationalSponsor: Vanderbilt-Ingram Cancer CenterUpdated: Sep 19, 2025Locations: 11
Eligibility criteria
Unilateral or bilateral intraocular retinoblastoma [+11]